11/14/2024
3:32 PM | Autolus Therapeutics (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
11/14/2024
8:12 AM | Autolus Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
11/12/2024
5:56 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
9:52 AM | Autolus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
09/26/2024
6:00 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
7:09 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
4:02 PM | Autolus Therapeutics (Subject)
Pule Martin (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/13/2024
8:08 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
7:27 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2024
3:35 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
4:15 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/21/2024
3:30 PM | Autolus Therapeutics (Subject)
Blackstone Inc. (Filed by)
| Form SC 13D/A | |
05/17/2024
7:27 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/13/2024
8:33 AM | Autolus Therapeutics (Filer)
| Form NT 10-Q | |
05/13/2024
6:23 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
6:06 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:10 PM | Autolus Therapeutics (Subject)
Kellnerova Renata (Filed by)
| Form SC 13D/A | |
03/21/2024
3:21 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:21 PM | Autolus Therapeutics (Filer)
| Form 8-K/A | |
03/14/2024
11:32 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/23/2024
4:28 PM | Autolus Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/14/2024
1:41 PM | ARMISTICE CAPITAL, LLC (Filed by)
Autolus Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
7:37 AM | Autolus Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:41 PM | Autolus Therapeutics (Subject)
Syncona Portfolio Ltd (Filed by)
| Form SC 13G/A | |
02/09/2024
4:15 PM | Autolus Therapeutics (Filer)
| Form 424B5 | |
02/08/2024
3:17 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/07/2024
9:00 PM | Autolus Therapeutics (Filer)
| Form S-3ASR | |
02/08/2024
5:06 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:10 PM | Autolus Therapeutics (Subject)
Tetragon Financial Management LP (Filed by)
| Form SC 13G/A | |
01/26/2024
12:02 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
2:12 PM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
7:24 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2023
7:31 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2023
6:07 AM | Autolus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
